Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: 4D Molecular Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
4D Molecular Therapeutics Inc. June 17, 202696.8%
-
Aldeyra Therapeutics Inc. June 4, 202463.5%
-
4D Molecular Therapeutics Inc. May 23, 202397.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 12, 2023 | Aldeyra Therapeutics Inc. | Open-market purchase | +509 | $10.13 | $5,156 |
| May 3, 2021 | Aldeyra Therapeutics Inc. | Open-market purchase | +413 | $12.81 | $5,291 |
Questions about Nancy Miller-Rich
What boards is Nancy Miller-Rich on?
Nancy Miller-Rich sits on the boards of 4D Molecular Therapeutics Inc. and Aldeyra Therapeutics Inc.
How long has Nancy Miller-Rich served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.